Catalyst Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
15.6513.6212.9212
Price/Sales ratio
3.823.402.903.07
Earnings per Share (EPS)
$1.28$1.48$1.56$1.68

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-12.28-9.79-4.81-18.22-5.7912.114.6117.7223.1425.0115.38-5.79
Price/Sales ratio
N/AN/AN/AN/A394.113.772.904.968.974.485.845.84
Price/Book Value ratio
5.403.572.214.143.884.402.033.386.404.606.033.88
Price/Cash Flow ratio
-14.72-10.99-4.84-24.41-7.6611.157.6711.5916.5612.4415.63-7.66
Price/Free Cash Flow ratio
-14.65-10.98-4.81-24.41-7.6311.157.6711.7916.57-32.5215.63-7.63
Price/Earnings Growth ratio
1.10-2.340.404.00-0.10-0.060.03-0.370.20-1.530.20-0.10
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/A-3883.84%85.57%85.69%84.46%83.94%78.77%84.56%-3883.84%
Operating Profit Margin
N/AN/AN/AN/A-7059.03%31.10%34.68%37.19%47.54%21.80%47.60%-7059.03%
Pretax Profit Margin
N/AN/AN/AN/A-6800.70%32.65%35.18%37.39%48.88%23.73%48.46%-6800.70%
Net Profit Margin
N/AN/AN/AN/A-6800.70%31.15%62.97%28.03%38.78%17.93%37.99%-6800.70%
Effective Tax Rate
-6.40%0.49%5.14%-0.76%-7.59%4.59%-78.99%25.03%20.66%24.44%21.59%-7.59%
Return on Assets
-35.32%-33.66%-43.33%-21.56%-56.25%28.36%38.98%16.60%22.11%15.18%31.39%-56.25%
Return On Equity
-44.00%-36.47%-45.97%-22.74%-66.95%36.37%44.21%19.08%27.65%18.41%45.72%-66.95%
Return on Capital Employed
-38.34%-36.00%-48.67%-23.02%-69.28%36.04%24.35%24.85%32.02%22.03%46.46%-69.28%
Liquidity Ratios
Current Ratio
7.4817.4119.7919.965.804.626.99N/AN/AN/A5.574.62
Quick Ratio
7.4817.4119.7919.965.794.536.797.475.452.675.364.53
Cash ratio
1.558.206.6313.471.743.715.726.335.181.805.181.74
Days of Sales Outstanding
N/AN/AN/AN/AN/A37.5918.3517.1517.7849.0512.2737.59
Days of Inventory outstanding
N/AN/AN/AN/A1.0248.3999.62131.2672.2167.5451.821.02
Operating Cycle
N/AN/AN/AN/A1.0285.98117.97148.4190.00116.6054.851.02
Days of Payables Outstanding
N/A18.99K7.84K15.54K42.82101.8291.1646.1642.1863.8830.27101.82
Cash Conversion Cycle
N/AN/AN/AN/A-41.80-15.8426.80102.2547.8252.71-5.21-41.80
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A0.00N/A0.010.000.000.200.20
Debt Equity Ratio
N/AN/AN/AN/AN/A0.00N/A0.010.010.000.250.25
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A0.00N/A0.010.010.000.010.00
Total Debt to Capitalization
N/AN/AN/AN/AN/A0.00N/A0.010.010.00N/A0.00
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A53.45N/A15.5032.6245.04N/A53.45
Company Equity Multiplier
1.241.081.061.051.191.281.131.141.251.211.251.19
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/A-51.400.330.370.420.540.360.37-51.40
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.0011.000.990.990.980.99-0.380.990.99
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A53.45N/A15.5032.6245.04N/A53.45
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A